DealsSep 15, 2026, 04:13 PM
Tempest Therapeutics Raises $2.5M in Private Placement
AI Summary
Tempest Therapeutics, Inc. announced the closing of a private placement on September 15, 2026, raising approximately $2.5 million in gross proceeds. The offering consisted of pre-funded warrants and Series C and D warrants to purchase shares of common stock. The company intends to use the net proceeds for working capital and general corporate purposes. As part of the agreement, Tempest will seek stockholder approval for the issuance of shares underlying the warrants within 90 days.
Key Highlights
- Tempest Therapeutics secured approximately $2.5 million in gross proceeds from a private placement.
- The private placement involved the sale of pre-funded warrants and Series C and D warrants.
- The company plans to use the net proceeds for working capital and general corporate purposes.
- Stockholder approval will be sought within 90 days for shares issuable upon warrant exercise.
- H.C. Wainwright & Co., LLC acted as the exclusive placement agent for the offering.
Price Impact
More from TPST